Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

Prognosis and clinical characteristics of signet ring cell colorectal peritoneal metastases – a Swedish population-based study

Enblad, Malin ; Ghanipour, Lana ; Palmer, Gabriella ; Valdimarsson, Valentinus LU orcid ; Bexe Lindskog, Elinor and Cashin, Peter (2025) In European Journal of Surgical Oncology 51(11).
Abstract

Background: Signet ring cell (SRC) colorectal cancer is strongly associated with peritoneal metastases (PM), but the role of cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) remains uncertain due to poor prognosis. This study aimed to analyse the prognostic impact of SRCs, assess clinical characteristics, and evaluate the risk of open-close laparotomy. Methods: This Swedish population-based study included patients with colorectal PM accepted for initial CRS and HIPEC at four national centres between 2010 and 2023. Data were retrieved from the Swedish HIPEC registry. Tumours with ≥50 % and <50 % SRCs were included. Results: Among 810 patients, 97 (12 %) had SRC tumours. SRC patients had a higher risk... (More)

Background: Signet ring cell (SRC) colorectal cancer is strongly associated with peritoneal metastases (PM), but the role of cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) remains uncertain due to poor prognosis. This study aimed to analyse the prognostic impact of SRCs, assess clinical characteristics, and evaluate the risk of open-close laparotomy. Methods: This Swedish population-based study included patients with colorectal PM accepted for initial CRS and HIPEC at four national centres between 2010 and 2023. Data were retrieved from the Swedish HIPEC registry. Tumours with ≥50 % and <50 % SRCs were included. Results: Among 810 patients, 97 (12 %) had SRC tumours. SRC patients had a higher risk of open-close laparotomy (22 % vs. 13 %, p = 0.04) and worse 5-year overall survival (OS) compared to non-SRC patients (18 % vs. 32 %, p = 0.004). SRC patients were younger, more often had synchronous PM, regional lymph node metastases, higher peritoneal cancer index, and were less likely to receive neoadjuvant treatment or have synchronous liver metastases. At diagnosis, PM were more often an unexpected intraoperative finding, and SRC patients exhibited a stronger preoperative systemic inflammatory response, with a higher CRP/albumin ratio. Among those undergoing CRS and HIPEC, the 5-year OS was 24 % (95 % CI: 14–40) in SRC patients and 36 % (95 % CI: 32–42, p = 0.056) in non-SRC patients. Conclusion: SRC colorectal PM is associated with a high risk of open-close laparotomy, poor prognosis, and distinct clinical features. These findings highlight the aggressive nature of SRCs but suggest that CRS and HIPEC should not be excluded for these patients.

(Less)
Please use this url to cite or link to this publication:
author
; ; ; ; and
organization
publishing date
type
Contribution to journal
publication status
published
subject
keywords
Colorectal cancer, Cytoreductive surgery, HIPEC, Peritoneal metastases, Signet ring cells
in
European Journal of Surgical Oncology
volume
51
issue
11
article number
110429
publisher
Elsevier
external identifiers
  • scopus:105014964147
  • pmid:40916313
ISSN
0748-7983
DOI
10.1016/j.ejso.2025.110429
language
English
LU publication?
yes
id
25e9aaef-8897-4468-9ff4-bea639503f87
date added to LUP
2025-10-03 14:11:16
date last changed
2025-11-28 19:27:35
@article{25e9aaef-8897-4468-9ff4-bea639503f87,
  abstract     = {{<p>Background: Signet ring cell (SRC) colorectal cancer is strongly associated with peritoneal metastases (PM), but the role of cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) remains uncertain due to poor prognosis. This study aimed to analyse the prognostic impact of SRCs, assess clinical characteristics, and evaluate the risk of open-close laparotomy. Methods: This Swedish population-based study included patients with colorectal PM accepted for initial CRS and HIPEC at four national centres between 2010 and 2023. Data were retrieved from the Swedish HIPEC registry. Tumours with ≥50 % and &lt;50 % SRCs were included. Results: Among 810 patients, 97 (12 %) had SRC tumours. SRC patients had a higher risk of open-close laparotomy (22 % vs. 13 %, p = 0.04) and worse 5-year overall survival (OS) compared to non-SRC patients (18 % vs. 32 %, p = 0.004). SRC patients were younger, more often had synchronous PM, regional lymph node metastases, higher peritoneal cancer index, and were less likely to receive neoadjuvant treatment or have synchronous liver metastases. At diagnosis, PM were more often an unexpected intraoperative finding, and SRC patients exhibited a stronger preoperative systemic inflammatory response, with a higher CRP/albumin ratio. Among those undergoing CRS and HIPEC, the 5-year OS was 24 % (95 % CI: 14–40) in SRC patients and 36 % (95 % CI: 32–42, p = 0.056) in non-SRC patients. Conclusion: SRC colorectal PM is associated with a high risk of open-close laparotomy, poor prognosis, and distinct clinical features. These findings highlight the aggressive nature of SRCs but suggest that CRS and HIPEC should not be excluded for these patients.</p>}},
  author       = {{Enblad, Malin and Ghanipour, Lana and Palmer, Gabriella and Valdimarsson, Valentinus and Bexe Lindskog, Elinor and Cashin, Peter}},
  issn         = {{0748-7983}},
  keywords     = {{Colorectal cancer; Cytoreductive surgery; HIPEC; Peritoneal metastases; Signet ring cells}},
  language     = {{eng}},
  number       = {{11}},
  publisher    = {{Elsevier}},
  series       = {{European Journal of Surgical Oncology}},
  title        = {{Prognosis and clinical characteristics of signet ring cell colorectal peritoneal metastases – a Swedish population-based study}},
  url          = {{http://dx.doi.org/10.1016/j.ejso.2025.110429}},
  doi          = {{10.1016/j.ejso.2025.110429}},
  volume       = {{51}},
  year         = {{2025}},
}